IPTAKALIM ATTENUATES SELF-ADMINISTRATION AND ACQUIRED GOAL-TRACKING BEHAVIOR CONTROLLED BY NICOTINE

Iptakalim is an ATP-sensitive potassium channel opener, as well as an α(4)β(2)-containing nicotinic acetylcholine receptor (nAChR) antagonist. Pretreatment with iptakalim diminishes nicotine-induced dopamine (DA) and glutamate release in the nucleus accumbens. This neuropharmacological profile sugge...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Charntikov, S., Swalve, N., Pittenger, S., Fink, K., Schepers, S., Hadlock, G. C., Fleckenstein, A. E., Hu, G., Li, M., Bevins, R. A.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3864985/
https://ncbi.nlm.nih.gov/pubmed/23916479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2013.07.019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars